The RAS-MEK-ERK pathway in low-grade serous ovarian cancer
Elizabeth H. Stover, Elizabeth K. Lee, Geoffrey I. Shapiro, Joan S. Brugge, Ursula A. Matulonis, Joyce Liu
Topics & Concepts
KRASTrametinibMedicineSelumetinibMEK inhibitorNeuroblastoma RAS viral oncogene homologMAPK/ERK pathwaySerous fluidOvarian cancerCancer researchOncologyInternal medicineClinical trialPI3K/AKT/mTOR pathwayCancerKinaseSignal transductionColorectal cancerBiologyBiochemistryCell biologyOvarian cancer diagnosis and treatmentCancer Mechanisms and TherapyFOXO transcription factor regulation